SC
BLUE

Schubert & Co’s bluebird bio BLUE Stock Holding History

Schubert & Co’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1
Closed – – 1087
2021
Q4 		$0 Buy
+1
New +$236 ﹤0.01% 1022

Other funds holding BLUE

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Schubert & Co's BLUE Position: Q1 2022 in Review

Schubert & Co sold out of bluebird bio (BLUE) in Q1 2022, closing a stake of 1 share.

Schubert & Co first reported a position in BLUE in Q4 2021 and held it in 1 quarter. The position peaked at $0 in Q4 2021. 174 funds tracked by Wall St. Rank hold BLUE as of Q1 2022.

  • Schubert & Co reported no remaining bluebird bio position as of Q1 2022 after selling out during the quarter.
  • Schubert & Co sold 1 bluebird bio share in Q1 2022.
  • Schubert & Co first reported a position in bluebird bio in Q4 2021 and held it in 1 quarter.
  • Schubert & Co's bluebird bio position peaked at $0 in Q4 2021.
  • 174 funds tracked by Wall St. Rank held bluebird bio as of Q1 2022.

Based on Schubert & Co's 13F filing for Q1 2022, filed 16 May 2022.